Page 15 - Benjamin Pinsky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The US is way behind on tracking COVID-19 variants Tara Santora © Provided by Popular Science By sequencing samples from COVID-19 patients, epidemiologists can track the virus as it mutates. New COVID-19 variants are turning up around the world—but none have made headlines like the so-called UK variant. The mutated form of the virus emerged across the pond in mid-December, and has already been found in 24 US states, totaling 293 cases, according to the Centers for Disease Control and Prevention. New Jersey also reported the nation’s first death from the variant on Wedne...

"Our numbers are down overall in the hospital," said Dr. Colwell, Chief of Emergency Medicine at ZSFG. Mayor London Breed tweeted, "San Francisco's COVID-19 reproductive rate is back under 1, at 0.99! That means for every person who gets COVID-19, on average they're passing it to less than one other person. We're slowing the spread. If this continues, we could soon start reopening under CA's guidelines." San Francisco's COVID-19 reproductive rate is back under 1, at 0.99! That means for every person who gets COVID-19, on average they're passing it to less than one other person. We're slowing...

Stanford Medicine launches large-scale surveillance of coronavirus variants in Bay Area Stanford Medicine researchers are screening diagnostic samples to identify known coronavirus variants circulating in the Bay Area, including those from the United Kingdom, South Africa and Brazil. Jan 21 2021 Benjamin Pinsky is the medical director of the Stanford Clinical Virology Laboratory, where researchers are screening samples for known coronavirus variants circulating in the Bay Area. Steve Fisch In March, Stanford Medicine was one of the first academic medical centers in the country t...

Updated Dec 28, 2020 | 10:05 IST A study suggests that coronavirus antibodies wane significantly within several months of infection and preferentially target a different part of the virus in mild cases than in comparison to severe ones. COVID-19 severity is affected by the proportion of antibodies targeting crucial viral protein | Photo Credit: Pixabay  Washington: Coronavirus antibodies wane significantly within several months of infection and preferentially target a different part of the virus in mild cases than in comparison to severe ones, suggest the findings o...

COVID-19 severity is affected by proportion of antibodies targeting crucial viral protein ANI | Updated: Dec 27, 2020 22:21 IST Washington [US], December 27 (ANI): Coronavirus antibodies wane significantly within several months of infection and preferentially target a different part of the virus in mild cases than in comparison to severe ones, suggest the findings of a new study. The findings which were published in Science Immunology identifies new links between the course of the disease and a patient's immune response to it. They also raise concerns abo...